相关实验视频

Updated: Jun 3, 2025

Magnetic Isolation of Microglial Cells from Neonate Mouse for Primary Cell Cultures

Magnetic Isolation of Microglial Cells from Neonate Mouse for Primary Cell Cultures

Published on: July 25, 2022

拜卡林通过PI3K/AKT/NF-κB信号通路向微质上的TLR4/MD2复合体来改善神经炎症

Yufang Lu¹, Ruiying Zhou¹, Ruyi Zhu¹

¹National Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest China, The Key Laboratory of Medicinal Resources and Natural Pharmaceutical Chemistry, The Ministry of Education, College of Life Sciences, Shaanxi Normal University, Xi'an, Shaanxi, 710119, China.

Neuropharmacology

|January 11, 2025

概括

拜卡林是一种天然的黄类化合物,通过向微质上Toll样受体4/骨髓分化蛋白2 (TLR4/MD2) 复合体来治疗神经炎症. 这减少了质细胞激活和促炎细胞因子,有助于脊髓损伤模型的恢复.

科学领域:

神经科学是一个神经科学.
免疫学免疫学免疫学
药理学药理学是指药理学的学科.

背景情况:

神经炎症,以质细胞激活和细胞因子释放为标志,是脊髓损伤 (SCI) 等疾病的核心.
托尔样受体4/骨髓分化蛋白2 (TLR4/MD2) 复合体对于先天性免疫反应和病原体识别至关重要.

研究的目的:

确定贝卡林在治疗神经炎症疾病中的治疗标和机制.
研究贝卡林对质细胞激活和SCI中的促炎性细胞因子水平的影响.

主要方法:

向SCI小鼠和脂聚糖化物 (LPS) 诱导的小鼠施用贝卡林.
评估了质细胞激活,细胞因子水平 (TNF-α,IL-1α,C1q),脱髓化和神经元损伤.
研究了贝卡林与TLR4/MD2复合物的相互作用及其对PI3K/AKT/NF-κB通路的影响.

主要成果:

在SCI小鼠中,百卡林显著降低了质细胞激活和促炎性细胞因子水平.
贝卡林减轻了脱和神经元损伤,表明神经保护.
拜卡林直接与TLR4/MD2复合体结合,抑制PI3K/AKT/NF-κB通路并调节星球细胞表型.

结论:

拜卡林通过直接向微质细胞和间接调节天体细胞,有效地减轻神经炎症.
贝卡林的机制包括抑制TLR4/MD2介导的PI3K/AKT/NF-κB通路.
贝卡林显示出作为神经炎症疾病治疗剂的潜力.

关键词:

星球细胞是星球细胞.贝卡林和贝卡林是什么意思微质细胞中的微质细胞神经炎症是一种神经炎症.在TLR/MD2蛋白质复合体中,

更多相关视频

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates

Published on: January 30, 2014

Development of an Insert Co-culture System of Two Cellular Types in the Absence of Cell-Cell Contact

Development of an Insert Co-culture System of Two Cellular Types in the Absence of Cell-Cell Contact

Published on: July 17, 2016

相关概念视频

NF-κB-dependent Signaling Pathway

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...

Inflammatory Bowel Disease IV: Pharmacological Management

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...